A citation-based method for searching scientific literature

S E Hankinson, J E Manson, D Spiegelman, W C Willett, C Longcope, F E Speizer. Cancer Epidemiol Biomarkers Prev 1995
Times Cited: 257







List of co-cited articles
313 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period.
Stacey A Missmer, Donna Spiegelman, Elizabeth R Bertone-Johnson, Robert L Barbieri, Michael N Pollak, Susan E Hankinson. Cancer Epidemiol Biomarkers Prev 2006
104
14


Determination of blood pressure percentiles in normal-weight children: some methodological issues.
B Rosner, N Cook, R Portman, S Daniels, B Falkner. Am J Epidemiol 2008
239
9


Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up.
Xuehong Zhang, Shelley S Tworoger, A Heather Eliassen, Susan E Hankinson. Breast Cancer Res Treat 2013
94
7

Distribution, variability, and predictors of urinary concentrations of phenols and parabens among pregnant women in Puerto Rico.
John D Meeker, David E Cantonwine, Luis O Rivera-González, Kelly K Ferguson, Bhramar Mukherjee, Antonia M Calafat, Xiaoyun Ye, Liza V Anzalota Del Toro, Noé Crespo-Hernández, Braulio Jiménez-Vélez,[...]. Environ Sci Technol 2013
219
7

A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development.
Shelley S Tworoger, A Heather Eliassen, Xuehong Zhang, Jing Qian, Patrick M Sluss, Bernard A Rosner, Susan E Hankinson. Cancer Res 2013
90
6



Plasma prolactin concentrations and risk of postmenopausal breast cancer.
Shelley S Tworoger, A Heather Eliassen, Bernard Rosner, Patrick Sluss, Susan E Hankinson. Cancer Res 2004
148
5

Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies.
T J Key, P N Appleby, G K Reeves, R C Travis, A J Alberg, A Barricarte, F Berrino, V Krogh, S Sieri, L A Brinton,[...]. Lancet Oncol 2013
157
5

Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer.
Shelley S Tworoger, Xuehong Zhang, A Heather Eliassen, Jing Qian, Graham A Colditz, Walter C Willett, Bernard A Rosner, Peter Kraft, Susan E Hankinson. J Clin Oncol 2014
39
12

Urinary phthalate metabolite concentrations among pregnant women in Northern Puerto Rico: distribution, temporal variability, and predictors.
David E Cantonwine, José F Cordero, Luis O Rivera-González, Liza V Anzalota Del Toro, Kelly K Ferguson, Bhramar Mukherjee, Antonia M Calafat, Noe Crespo, Braulio Jiménez-Vélez, Ingrid Y Padilla,[...]. Environ Int 2014
116
5

Temporal variability of urinary phthalate metabolite levels in men of reproductive age.
Russ Hauser, John D Meeker, Sohee Park, Manori J Silva, Antonia M Calafat. Environ Health Perspect 2004
292
5

The Nurses' Health Study: lifestyle and health among women.
Graham A Colditz, Susan E Hankinson. Nat Rev Cancer 2005
399
5

Statistical methods for studying disease subtype heterogeneity.
Molin Wang, Donna Spiegelman, Aya Kuchiba, Paul Lochhead, Sehee Kim, Andrew T Chan, Elizabeth M Poole, Rulla Tamimi, Shelley S Tworoger, Edward Giovannucci,[...]. Stat Med 2016
138
5

Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Rudolf Kaaks, Franco Berrino, Timothy Key, Sabina Rinaldi, Laure Dossus, Carine Biessy, Giorgio Secreto, Pilar Amiano, Sheila Bingham, Heiner Boeing,[...]. J Natl Cancer Inst 2005
292
4

Plasma androgen concentrations and risk of incident ovarian cancer.
Shelley S Tworoger, I-Min Lee, Julie E Buring, Susan E Hankinson. Am J Epidemiol 2008
31
12

Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort.
K Tikk, D Sookthai, T Johnson, S Rinaldi, I Romieu, A Tjønneland, A Olsen, K Overvad, F Clavel-Chapelon, L Baglietto,[...]. Ann Oncol 2014
45
8


Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women.
S E Hankinson, W C Willett, J E Manson, D J Hunter, G A Colditz, M J Stampfer, C Longcope, F E Speizer. J Natl Cancer Inst 1995
355
4

Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.
S E Hankinson, W C Willett, J E Manson, G A Colditz, D J Hunter, D Spiegelman, R L Barbieri, F E Speizer. J Natl Cancer Inst 1998
448
4

Association between sex hormones and colorectal cancer risk in men and women.
Jennifer H Lin, Shumin M Zhang, Kathryn M Rexrode, Joann E Manson, Andrew T Chan, Kana Wu, Shelley S Tworoger, Susan E Hankinson, Charles Fuchs, J Michael Gaziano,[...]. Clin Gastroenterol Hepatol 2013
76
5

Flexible regression models with cubic splines.
S Durrleman, R Simon. Stat Med 1989
4

Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study.
Rebecca E James, Annekatrin Lukanova, Laure Dossus, Susen Becker, Sabina Rinaldi, Anne Tjønneland, Anja Olsen, Kim Overvad, Sylvie Mesrine, Pierre Engel,[...]. Cancer Prev Res (Phila) 2011
79
5

Temporal variability and predictors of urinary bisphenol A concentrations in men and women.
Shruthi Mahalingaiah, John D Meeker, Kimberly R Pearson, Antonia M Calafat, Xiaoyun Ye, John Petrozza, Russ Hauser. Environ Health Perspect 2008
213
4

Variability of urinary concentrations of bisphenol A in spot samples, first morning voids, and 24-hour collections.
Xiaoyun Ye, Lee-Yang Wong, Amber M Bishop, Antonia M Calafat. Environ Health Perspect 2011
192
4

Variability of urinary phthalate metabolite and bisphenol A concentrations before and during pregnancy.
Joe M Braun, Kristen W Smith, Paige L Williams, Antonia M Calafat, Katharine Berry, Shelley Ehrlich, Russ Hauser. Environ Health Perspect 2012
216
4

Temporal variability in urinary concentrations of phthalate metabolites, phytoestrogens and phenols among minority children in the United States.
S L Teitelbaum, J A Britton, A M Calafat, X Ye, M J Silva, J A Reidy, M P Galvez, B L Brenner, M S Wolff. Environ Res 2008
258
4


Internalizing disorders and leukocyte telomere erosion: a prospective study of depression, generalized anxiety disorder and post-traumatic stress disorder.
I Shalev, T E Moffitt, A W Braithwaite, A Danese, N I Fleming, S Goldman-Mellor, H L Harrington, R M Houts, S Israel, R Poulton,[...]. Mol Psychiatry 2014
106
4




A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
Shelley S Tworoger, A Heather Eliassen, Patrick Sluss, Susan E Hankinson. J Clin Oncol 2007
137
3

European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection.
E Riboli, K J Hunt, N Slimani, P Ferrari, T Norat, M Fahey, U R Charrondière, B Hémon, C Casagrande, J Vignat,[...]. Public Health Nutr 2002
3

Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort.
Rudolf Kaaks, Kaja Tikk, Disorn Sookthai, Helena Schock, Theron Johnson, Anne Tjønneland, Anja Olsen, Kim Overvad, Françoise Clavel-Chapelon, Laure Dossus,[...]. Int J Cancer 2014
46
6

Serum gonadotropins and steroid hormones and the development of ovarian cancer.
K J Helzlsouer, A J Alberg, G B Gordon, C Longcope, T L Bush, S C Hoffman, G W Comstock. JAMA 1995
122
3

Hormone response in ovarian cancer: time to reconsider as a clinical target?
Francesmary Modugno, Robin Laskey, Ashlee L Smith, Courtney L Andersen, Paul Haluska, Steffi Oesterreich. Endocr Relat Cancer 2012
71
4

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.
Weiva Sieh, Martin Köbel, Teri A Longacre, David D Bowtell, Anna deFazio, Marc T Goodman, Estrid Høgdall, Suha Deen, Nicolas Wentzensen, Kirsten B Moysich,[...]. Lancet Oncol 2013
209
3



Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop.
C V Clevenger, W P Chang, W Ngo, T L Pasha, K T Montone, J E Tomaszewski. Am J Pathol 1995
167
3

Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden).
Jonas Manjer, Robert Johansson, Göran Berglund, Lars Janzon, Rudolf Kaaks, Asa Agren, Per Lenner. Cancer Causes Control 2003
64
4


Bioactive prolactin levels and risk of breast cancer: a nested case-control study.
Shelley S Tworoger, Megan S Rice, Bernard A Rosner, Yvonne B Feeney, Charles V Clevenger, Susan E Hankinson. Cancer Epidemiol Biomarkers Prev 2015
24
12

Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women.
Yngve Bremnes, Giske Ursin, Nils Bjurstam, Sabina Rinaldi, Rudolf Kaaks, Inger T Gram. Int J Cancer 2007
48
6

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Stacey A Missmer, A Heather Eliassen, Robert L Barbieri, Susan E Hankinson. J Natl Cancer Inst 2004
323
3


Temporal variability in urinary excretion of bisphenol A and seven other phenols in spot, morning, and 24-h urine samples.
Tina Harmer Lassen, Hanne Frederiksen, Tina Kold Jensen, Jørgen Holm Petersen, Katharina M Main, Niels E Skakkebæk, Niels Jørgensen, Selma Kløve Kranich, Anna-Maria Andersson. Environ Res 2013
75
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.